المؤلفون: Saunders MP; The Christie, Manchester, United Kingdom. Electronic address: mark.saunders8@nhs.net., Iype R; The Christie, Manchester, United Kingdom., Kelly C; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, United Kingdom., Crosby J; Queen Elizabeth University Department of Pathology and Biorepository, Glasgow, United Kingdom., Kerr R; University of Oxford, Oxford, United Kingdom., Harkin A; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, United Kingdom., Allan K; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, United Kingdom., McQueen J; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, United Kingdom., Pearson SR; OCTO, University of Oxford, Oxford, United Kingdom., Cassidy J; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, United Kingdom., Medley LC; Royal United Hospital Bath, Bath, United Kingdom; South Devon Healthcare NHS Foundation Trust, Torquay, United Kingdom., Raouf S; Barts Health NHS Trust, London, United Kingdom., Harrison M; Mount Vernon Hospital, Northwood, United Kingdom., Brewster A; Velindre Cancer Centre, Cardiff, United Kingdom., Rees C; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom; Hampshire Hospitals NHS Foundation Trust, Basingstoke, United Kingdom., Ellis R; Royal Cornwall Hospital, Truro, United Kingdom., Thomas AL; University of Leicester, Leicester, United Kingdom., Churn M; Worcester Royal Hospital, Worcester, United Kingdom., Iveson T; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom., Maka N; Queen Elizabeth University Department of Pathology and Biorepository, Glasgow, United Kingdom.

المصدر: Clinical colorectal cancer [Clin Colorectal Cancer] 2023 Jun; Vol. 22 (2), pp. 231-237. Date of Electronic Publication: 2023 Feb 22.

نوع المنشور: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101120693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0674 (Electronic) Linking ISSN: 15330028 NLM ISO Abbreviation: Clin Colorectal Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/pathology, Humans ; Disease-Free Survival ; Prognosis ; Oxaliplatin/therapeutic use ; Chemotherapy, Adjuvant ; Neoplasm Staging ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Retrospective Studies

المؤلفون: Hu JC; Department of Cancer Medicine, Imperial College School of Medicine, Royal Marsden Hospital, London, UK., Coffin RS, Davis CJ, Graham NJ, Groves N, Guest PJ, Harrington KJ, James ND, Love CA, McNeish I, Medley LC, Michael A, Nutting CM, Pandha HS, Shorrock CA, Simpson J, Steiner J, Steven NM, Wright D, Coombes RC

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2006 Nov 15; Vol. 12 (22), pp. 6737-47.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Print ISSN: 1078-0432 (Print) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Simplexvirus*/immunology , Simplexvirus*/metabolism, Granulocyte-Macrophage Colony-Stimulating Factor/*therapeutic use , Neoplasms/*therapy , Oncolytic Virotherapy/*methods, Adult ; Aged ; Aged, 80 and over ; Antibodies, Antinuclear/blood ; Biopsy ; Breast Neoplasms/pathology ; Breast Neoplasms/therapy ; Carcinoma/pathology ; Carcinoma/therapy ; Colorectal Neoplasms/pathology ; Colorectal Neoplasms/therapy ; Cytokines/blood ; Female ; Granulocyte-Macrophage Colony-Stimulating Factor/administration & dosage ; Granulocyte-Macrophage Colony-Stimulating Factor/adverse effects ; Granulocyte-Macrophage Colony-Stimulating Factor/metabolism ; Head and Neck Neoplasms/pathology ; Head and Neck Neoplasms/therapy ; Humans ; Male ; Melanoma/pathology ; Melanoma/therapy ; Middle Aged ; Oncolytic Virotherapy/adverse effects ; Oncolytic Viruses ; Recombinant Proteins ; Skin Neoplasms/pathology ; Skin Neoplasms/therapy ; Treatment Outcome